SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Medical - Healthcare >

Paradigm Medical Industries Inc. (PDMI)

Add PDMI Price Alert      Hide Sticky   Hide Intro
Moderator: Risk vs Reward
Search This Board: 
Last Post: 2/20/2017 9:31:03 AM - Followers: 302 - Board type: Free - Posts Today: 2

Paradigm Medical Industries, Inc.


Contact Info
  • 4273 South 590 West
  • Salt Lake City, UT 84123
Press Releases

Paradigm Medical Industries (PDMI)

Originally the creation of a merger between French Bar Industries and Paradigm Medical Inc. in early 1993, the company quickly became skilled in the development, manufacturing, sales, and marketing of medical devices utilizing innovative and dependable diagnostic technologies for the early detection of glaucoma and other eye disorders. 

Paradigm Medical Industries, Inc. has an exceptional history of acquiring superior medical devices and companies. In 1997 Paradigm acquired OBF Labs and the Ocular Blood Flow Analyzer (BFA). Today the BFA is the only medical device available that measures both IOP and Ocular Blood Flow, two key factors in the assessment and early treatment of glaucoma, circulatory abnormalities, and other eye maladies. In 1998 the company acquired proprietary UBM technology from Humphrey Systems. After extensive research and development Paradigm enhanced this technology to be more precise, user friendly, and detailed with its introduction of the P60 UBM, the first Windows based UBM, in early 2005. In 2000 Paradigm acquired Dicon, a manufacturer of advanced diagnostic instrumentation, and expanded its product line to include perimetry, topography, and pachymetry. Only Paradigm’s sophisticated perimeters perform testing strategies with voice recognition software, now available in 26 languages. Paradigm remains dedicated to developing or acquiring new technologies and devices that preserve the vision of tomorrow, today. 

Paradigm’s expertise lies with medical devices using UBM, A-scan, B-scan, pachymetry, perimetry, ocular electrophysiology, topography, tomography, and tonometry technologies. With over 17 years of experience Paradigm specializes in providing reliable, easy-to use equipment that provide the experienced practitioner unequalled value and performance, while remaining affordable for physicians starting new practices or opening up additional satellite offices. 

Paradigm Medical Industries, Inc. is a publicly owned company traded on the OTC/PK under the symbol

Two Consultants for PDMI
Steven Bayern & Thomas F. Motter 

Steven Bayern BIO 
Listed as Consultant in PR 


Mr. Bayern has over 30 years of experience in investment banking, venture capital, and trading 
and brokerage management, including having founded and served as a principal in three separate brokerage firms on Wall Street. He was founder and principal of Racz & Company, a NYSE member firm, founder and Chairman of S.J. Bayern & Company, an NASD member firm, and founder and Chairman of Win Capital Corporation, also an NASD member firm. Mr. Bayern was also involved in successfully raising capital for Paradigm Medical in 2001 and 2003, and in arranging for the merger between the Company and Vismed, Inc., dba Dicon in 2000. 

Holding an MBA from the Baruch School of Business CCNY earned in 1974, in Finance and Investments, Mr. Bayern has built his career in the financial industry based upon his ability to locate, structure and fund small cap and mid-market deals. To that end, he has consummated myriad transactions throughout his career while compiling a long and distinguished track record of success. 

In his capacity as a principal in broker/dealer ventures, Mr. Bayern has assisted a great many small and mid-size companies achieve public listing and trading status and is intimately familiar with the public equity markets on both the buy and sell sides. 

Having worked with numerous companies throughout the course of his career and having raised many hundreds of millions of dollars in equity capital for them, Mr. Bayern brings an invaluable skill-set and wealth of experience to any company in search of capital. His ability to locate, structure and shepherd transactions throughout the process is critical and his connections at virtually every level of Wall Street is of vital importance to any company seeking seed, bridge, mezzanine or ongoing capital up to and beyond the domestic sources serve to compliment the success of any client’s funding endeavors. 

Racz & Company Mentioned here in NY Times Article 1981 

Thomas F. Motter is no scrub promoter IMO... Check out his BIO 

Mr. Motter has worked in the eye care industry for over 30 years, including management 
positions at SmithKline Beckman's eye division over a 15 year period. Mr. Motter founded Paradigm 
Medical and served as Chairman of the Board and Chief Executive Officer of the Company from 1993 
to 2002. As founder of Paradigm Medical, Mr. Motter pioneered the use of Nd-yag laser for cataract 
removal and was at the forefront in the introduction of new surgical procedures utilizing ultrasound and 
laser technologies in all facets of soft tissue management.

SmithKline Beckman was merged with what ultimately became GSK one of the largest pharma companies behind Pfizer 

The Beecham Group plc was a British pharmaceutical company. It was once a constituent of the FTSE 100 Index. Beecham, after having merged with SmithKline Beckman, merged with Glaxo Wellcome to become GlaxoSmithKline (GSK). GSK still uses the Beechams brand name in the UK for its over-the-counter cold and flu relief products.


Randall A. Mackey

Chairman of the Board of Directors, PDMI

Attorney and Counselor at Law at Mackey Price & Mecham



After receiving his two law degrees, Mr. Mackey joined the law firm of Hogan & Hartson in Washington, D.C. where he practiced extensively in the areas of corporate and securities law and administrative law. In 1979, he returned to Utah and joined the Salt Lake City law firm of Fabian & Clendenin. He was a shareholder, Vice President, and a director of that firm prior to joining the predecessor of Mackey Price & Mecham in 1989. While at Fabian & Clendenin, Mr. Mackey’s principal areas of practice included corporate and securities law and banking law. Mr. Mackey also served from 1981 to 1988 as an Adjunct Professor at the University of Utah, teaching courses in Constitutional Law and International Law.

Mr. Mackey has been active in community affairs. He has previously served as Chairman of the Board of Trustees of Salt Lake Community College, a member of the Utah State Board of Education, a director of the Harvard Alumni Association in Cambridge, Massachusetts, a Vice President of the Columbia Law School Association in New York City, and a director of the Salt Lake Education Foundation. Mr. Mackey has also served as a trustee of Ballet West, the Utah Opera Company, and the Gina Bachauer International Piano Foundation and a director of the Utah Arts Counsel.

Mr. Mackey additionally served on the Utah National Steering Committee in 1992 and 1988 of President George Bush’s Campaign Committee, as Chairman of the Higher Education Committee for Governor Jon Huntsman’s Campaign Committee in 2004, a member of Governor Huntsman’s Transition Committee from 2004 to 2005, a member of the Steering Committee of Governor Michael Leavitt’s Campaign Committee in 1992, and a member of the Executive Committee of Governor Leavitt’s Transition Committee from 1992 to 1993.

Mr. Mackey is a member of the Utah State Bar and the District of Columbia Bar and served on the Utah State Bar Securities Advisory Committee.


Extensive experience in corporate and securities matters, including mergers and acquisitions, public offerings and private placements of equity and debt securities, business planning, business sales and divestitures, securities law compliance, shareholder matters, proxy contests, tender offers, joint ventures, limited liability company law, commercial law and insurance law. Has also had significant experience in banking work.


Mackey Price & Mecham is a business law firm based in Salt Lake City, Utah. The firm’s areas of practice include general corporate, corporate finance and securities, litigation and alternative dispute resolution, real estate, banking, estate planning, and aviation law. Mackey Price & Mecham was founded to service the needs of business organizations and enjoys a broad-based business practice.

The firm has two principal objectives: first, to provide mature businesses with the entire spectrum of corporate legal and dispute resolution services at a high level of expertise, and second, to provide emerging businesses with assistance in corporate organization, finance and capital formation, and dispute resolution (as well as assisting with the many other legal and business issues facing emerging businesses). In the past, many top Utah businesses have hired out-of-state legal counsel for representation in complex corporate and securities transactions. Mackey Price & Mecham provides the same quality of legal services on a local basis that are usually found among large out-of-state law firms.

The firm’s attorneys believe that the Rocky Mountain region is an attractive growth area for businesses. Growing businesses need quality representation from experienced legal counsel. Such counsel can facilitate a client’s growth by advising the client on how to locate sources of, and secure capital, assemble a team of professionals and management personnel, and resolve problems and disputes that might inhibit future growth and development. The attorneys at Mackey Price & Mecham are confident that their experience enables them to act as catalysts to the entrepreneurial spirit that prevails in the Rocky Mountain region.

Attorney and Counselor at Law

Fabian & Clendenin

Principal areas of practice included corporate and securities law and banking law.

Attorney and Counselor at Law

Hogan & Hartson

Practiced extensively in the areas of corporate and securities law and administrative law.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#23121   Forgot it's Pres Day ( closed ) Risk vs Reward 02/20/17 09:31:03 AM
#23120   Let's see some 2's today !! Risk vs Reward 02/20/17 07:08:07 AM
#23119   Well guys , looks like WillieWonka 02/17/17 04:01:35 PM
#23118   No its not that. WillieWonka 02/17/17 01:17:12 PM
#23117   I think someone's trying accumulate 1 million shares Risk vs Reward 02/17/17 12:26:30 PM
#23116   You hit the nail on the head! Just WillieWonka 02/17/17 08:18:21 AM
#23115   If there's always a buyer when there is Risk vs Reward 02/16/17 06:49:11 PM
#23114   Hopefully it was a new investor, WillieWonka 02/16/17 05:19:36 PM
#23113   It's both. For every buyer, there is WillieWonka 02/16/17 05:17:42 PM
#23112   Sorry for the dumb question but is that Risk vs Reward 02/16/17 04:23:29 PM
#23111   Was that actually a buy and not someone Risk vs Reward 02/16/17 04:20:40 PM
#23110   Sorry about the double post guys. By the way, WillieWonka 02/16/17 03:52:40 PM
#23108   Anyone here pick up that block of 6,000,000? WillieWonka 02/16/17 03:20:33 PM
#23107   We have to have days like this for WillieWonka 02/16/17 03:11:33 PM
#23106   Any takers lol ? Risk vs Reward 02/16/17 02:17:08 PM
#23105   Bang! 6 million ones up for purchase Risk vs Reward 02/16/17 02:16:19 PM
#23104   Still asking 2 Risk vs Reward 02/16/17 12:09:41 PM
#23103   Had a bid for a little bit. WillieWonka 02/16/17 10:06:18 AM
#23102   Good day from a High and Low price WillieWonka 02/14/17 04:25:34 PM
#23101   A 250k banger!!! Don't look now Wonka, you Risk vs Reward 02/14/17 02:21:13 PM
#23100   27.8 @ .0002 Risk vs Reward 02/14/17 11:40:16 AM
#23099   Another 10k buy, I'll take it. Any action Risk vs Reward 02/14/17 11:39:48 AM
#23098   I agree, but Bayern and Motter have to WillieWonka 02/13/17 06:17:15 PM
#23097   Big Daddy Business will definitely be the small Risk vs Reward 02/13/17 05:25:20 PM
#23096   Yeah I'd love to see just a simple Risk vs Reward 02/13/17 05:23:39 PM
#23095   That's all well and good Sure Bet, but WillieWonka 02/13/17 12:30:33 PM
#23094   Trump will be great for small businesses cutting sure bet 02/13/17 12:04:55 PM
#23093   Another point I wanted to make is that WillieWonka 02/13/17 11:46:31 AM
#23092   I think at this point we can all say WillieWonka 02/13/17 11:36:30 AM
#23091   Lowest ASK size @ 2 I've seen Risk vs Reward 02/13/17 09:55:02 AM
#23090   It was only 10,000, I checked the time WillieWonka 02/08/17 04:06:26 PM
#23089   30,000 2's... well it's start lol Risk vs Reward 02/08/17 03:31:52 PM
#23088   Lets see if she closes with a bid. WillieWonka 02/08/17 03:08:49 PM
#23087   That is good. WillieWonka 02/08/17 11:01:29 AM
#23086   Bid! Risk vs Reward 02/08/17 10:23:33 AM
#23085   Thanks. WillieWonka 02/07/17 04:13:34 PM
#23084   I can't find anything on those 2 guys, Risk vs Reward 02/07/17 02:26:58 PM
#23083   Honestly Risk, the only things I am WillieWonka 02/07/17 09:51:15 AM
#23082   That's why I brought it up again, you Risk vs Reward 02/06/17 07:01:59 PM
#23081   This goes to the point I made WillieWonka 02/06/17 05:46:06 PM
#23080   Someone keeps paying the fees on this or Risk vs Reward 02/06/17 05:28:46 PM
#23079   Don't know if he is still taking calls. WillieWonka 02/06/17 11:13:15 AM
#23078   Is Mackey still taking calls? Maybe I should Risk vs Reward 02/04/17 10:13:41 AM
#23077   O.K. start to Friday. WillieWonka 02/03/17 10:40:26 AM
#23076   3 shares cost .0003 @ .0001 that's almost Risk vs Reward 02/02/17 11:30:49 AM
#23075   There you go, it all makes WillieWonka 02/01/17 09:03:49 AM
#23074   This is an optical play and Mary Jane Risk vs Reward 01/31/17 06:36:21 PM
#23073   Whatever it takes Kittie. WillieWonka 01/31/17 02:51:20 PM
#23072   Maybe PDMI should say they r a MJ company kittie88 01/30/17 09:08:48 PM
#23071   I been here since 2003, always something cooking kittie88 01/30/17 09:04:10 PM